nonarteritic anterior ischemic optic neuropathy

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nonarteritic Anterior Ischemic Optic Neuropathy Trial in United States (RPh201 Cohort A, Placebo Cohort A, RPh201 Cohort B)

Terminated
  • Nonarteritic Anterior Ischemic Optic Neuropathy
  • RPh201 Cohort A
  • +3 more
  • Palo Alto, California
  • +14 more
Oct 8, 2020

NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

Completed
  • Nonarteritic Anterior Ischemic Optic Neuropathy
  • PDE5 Inhibitors
  • Birmingham, Alabama
  • +43 more
Sep 5, 2017

Nonarteritic Anterior Ischemic Optic Neuropathy Trial in Aurora (ranibizumab)

Completed
  • Nonarteritic Anterior Ischemic Optic Neuropathy
  • Aurora, Colorado
    Rocky Mountain Lions Eye Institute
Aug 23, 2016

Nonarteritic Anterior Ischemic Optic Neuropathy Trial in Tehran (levodopa-carbidopa)

Completed
  • Nonarteritic Anterior Ischemic Optic Neuropathy
  • Tehran, Iran, Islamic Republic of
    Ophthalmic research center
Oct 17, 2008